Hemophilia B is a genetic condition that limits your blood’s ability to clot. Without prompt treatment, it can become a life threatening emergency. Creating a plan can help you better manage ...

Gene therapy has been available since 2022 for hemophilia B and since 2023 for hemophilia A, yet some major medical institutions have barely treated any patients so far. What’s the holdup?

This advertisement has not loaded yet, but your article continues below.

This advertisement has not loaded yet, but your article continues below.

A recent study led by MedUni Vienna provides new insights into the mechanisms of coagulation in persons with hemophilia A, the most common form of hemophilia. The research team was able to show ...

Michael Ramirez cartoon on Donald Trump’s messy policies.

This advertisement has not loaded yet, but your article continues below.

“Act now—the first fifty callers receive a Presidential pardon.” ...

Bill Bramhall's editorial cartoon for Friday, Aug. 4, 2023, shows the defense saying, "It's not ...

Factor VIII gene was introduced into hematopoietic stem cells in men with hemophilia. The annualized bleeding rate went from 10 to 0. No worrisome gene integrations were seen. The content of this ...

Metagenomi is now working on preclinical studies to advance MGX-001, its experimental gene-editing therapy for hemophilia A, with the goal of bringing the treatment candidate into clinical trials in ...